SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-089925
Filing Date
2023-11-24
Accepted
2023-11-24 17:08:30
Documents
15
Period of Report
2023-11-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea188973-8k_elevailabs.htm   iXBRL 8-K 38969
2 FORM OF UNDERWRITER'S WARRANTS ea188973ex4-1_elevailabs.htm EX-4.1 95181
3 FORM OF LOCK-UP AGREEMENT ea188973ex10-1_elevailabs.htm EX-10.1 24336
4 PRESS RELEASE OF THE COMPANY DATED AS OF NOVEMBER 24, 2023 ea188973ex99-1_elevailabs.htm EX-99.1 10663
  Complete submission text file 0001213900-23-089925.txt   377991

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE elab-20231120.xsd EX-101.SCH 3030
6 XBRL LABEL FILE elab-20231120_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE elab-20231120_pre.xml EX-101.PRE 22369
9 EXTRACTED XBRL INSTANCE DOCUMENT ea188973-8k_elevailabs_htm.xml XML 3408
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 18667944940
Elevai Labs Inc. (Filer) CIK: 0001840563 (see all company filings)

IRS No.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 231437089
SIC: 2834 Pharmaceutical Preparations